Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancer.
| Image |  |
|---|---|
| Description | scientific article published on 20 October 2014 |
| Author/s |
author: Javier Cortes Sandra M. Swain Seock-Ah Im |
| Publication date | October 20, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |